[The novel coronavirus Covid-19: What are the ophthalmic risks?]

doi:10.1016/j.jfo.2020.02.001

Editorial

. 2020 Apr;43(4):291-293.

doi: 10.1016/j.jfo.2020.02.001. Epub 2020 Mar 9.

[The novel coronavirus Covid-19: What are the ophthalmic risks?]

[Article in French]

R Tahiri Joutei Hassani¹, O Sandali²

Affiliations

¹ Service de chirurgie ambulatoire, centre hospitalier d'Avranches Granville, 849, rue des Menneries, 50400 Granville, France. Electronic address: tjhr78@hotmail.com.
² Service de chirurgie ambulatoire, clinique Guillaume-de-Varye, Bourges, France.

PMID: 32165057
PMCID: PMC7134524
DOI: 10.1016/j.jfo.2020.02.001

Editorial

[The novel coronavirus Covid-19: What are the ophthalmic risks?]

[Article in French]

R Tahiri Joutei Hassani et al. J Fr Ophtalmol. 2020 Apr.

. 2020 Apr;43(4):291-293.

doi: 10.1016/j.jfo.2020.02.001. Epub 2020 Mar 9.

Authors

R Tahiri Joutei Hassani¹, O Sandali²

Affiliations

¹ Service de chirurgie ambulatoire, centre hospitalier d'Avranches Granville, 849, rue des Menneries, 50400 Granville, France. Electronic address: tjhr78@hotmail.com.
² Service de chirurgie ambulatoire, clinique Guillaume-de-Varye, Bourges, France.

PMID: 32165057
PMCID: PMC7134524
DOI: 10.1016/j.jfo.2020.02.001

No abstract available

PubMed Disclaimer

Comment on

2019-nCoV transmission through the ocular surface must not be ignored.
Lu CW, Liu XF, Jia ZF. Lu CW, et al. Lancet. 2020 Feb 22;395(10224):e39. doi: 10.1016/S0140-6736(20)30313-5. Epub 2020 Feb 6. Lancet. 2020. PMID: 32035510 Free PMC article. No abstract available.

Cited by

[SARS-CoV-2, COVID-19 and the eye: An update on published data].
Rousseau A, Fenolland JR, Labetoulle M. Rousseau A, et al. J Fr Ophtalmol. 2020 Sep;43(7):642-652. doi: 10.1016/j.jfo.2020.05.003. Epub 2020 May 30. J Fr Ophtalmol. 2020. PMID: 32631687 Free PMC article. Review. French.
Deep learning based detection and analysis of COVID-19 on chest X-ray images.
Jain R, Gupta M, Taneja S, Hemanth DJ. Jain R, et al. Appl Intell (Dordr). 2021;51(3):1690-1700. doi: 10.1007/s10489-020-01902-1. Epub 2020 Oct 9. Appl Intell (Dordr). 2021. PMID: 34764553 Free PMC article.
Covid-19, ocular manifestation and ophthalmic risks.
Joob B, Wiwanitkit V. Joob B, et al. J Fr Ophtalmol. 2020 Sep;43(7):e231. doi: 10.1016/j.jfo.2020.04.021. Epub 2020 Jun 6. J Fr Ophtalmol. 2020. PMID: 32553398 Free PMC article. No abstract available.
[Impact of COVID-19 on ophthalmology consultations: survey among 35 ophthalmologists].
Louaya S, Moustaine O, Badaoui M, Hnach Y, Alaayoud A, Chatoui S. Louaya S, et al. Pan Afr Med J. 2020 Jul 8;36:163. doi: 10.11604/pamj.2020.36.163.23468. eCollection 2020. Pan Afr Med J. 2020. PMID: 32952807 Free PMC article. French.
Detail-Oriented Capsule Network for classification of CT scan images performing the detection of COVID-19.
Modi S, Guhathakurta R, Praveen S, Tyagi S, Bansod SN. Modi S, et al. Mater Today Proc. 2023;80:3709-3713. doi: 10.1016/j.matpr.2021.07.367. Epub 2021 Jul 22. Mater Today Proc. 2023. PMID: 34312594 Free PMC article.

References

1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed
1. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report–36: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... (accessed 25 Feb 2020).
1. World Health Organization (WHO). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-...) (accessed 22 Feb 2020).
1. Chen J. Pathogenicity and transmissibility of 2019-nCoV – A quick overview and comparison with other emerging viruses. Microbes Infect. 2020 doi: 10.1016/j.micinf.2020.01.004. pii: S1286-4579(20)30026-5. [Epub ahead of print] - DOI - PMC - PubMed
1. Lu C.W., Liu X.F., Jia Z.F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020 doi: 10.1016/S0140-6736(20)30313-5. Feb 6. pii: S0140-6736(20)30313-5. - DOI - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed

[2] Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed

[3] World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report–36: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... (accessed 25 Feb 2020).

[4] World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) Situation Report–36: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... (accessed 25 Feb 2020).

[5] World Health Organization (WHO). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-...) (accessed 22 Feb 2020).

[6] World Health Organization (WHO). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-...) (accessed 22 Feb 2020).

[7] Chen J. Pathogenicity and transmissibility of 2019-nCoV – A quick overview and comparison with other emerging viruses. Microbes Infect. 2020 doi: 10.1016/j.micinf.2020.01.004. pii: S1286-4579(20)30026-5. [Epub ahead of print] - DOI - PMC - PubMed

[8] Chen J. Pathogenicity and transmissibility of 2019-nCoV – A quick overview and comparison with other emerging viruses. Microbes Infect. 2020 doi: 10.1016/j.micinf.2020.01.004. pii: S1286-4579(20)30026-5. [Epub ahead of print] - DOI - PMC - PubMed

[9] Lu C.W., Liu X.F., Jia Z.F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020 doi: 10.1016/S0140-6736(20)30313-5. Feb 6. pii: S0140-6736(20)30313-5. - DOI - PMC - PubMed

[10] Lu C.W., Liu X.F., Jia Z.F. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020 doi: 10.1016/S0140-6736(20)30313-5. Feb 6. pii: S0140-6736(20)30313-5. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

[The novel coronavirus Covid-19: What are the ophthalmic risks?]

Affiliations

[The novel coronavirus Covid-19: What are the ophthalmic risks?]

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources